Set Home | Favorites 中文 English
Project Description
Project Name
Chikungunya Vaccine
Mark as important: Time(s)
Browse:2587 Time(s)
Project Type Equity investment projects

Investment Mode
Industry  Pharmaceutical manufacturing industry
Project Advantages
Project validity period Six months
Mark general 
Project properties encouraged
Estimated Investment
Total amount of project capitals 5 Ten thousand U.S. dollars
Total amount of investment to be attracted 3 Ten thousand U.S. dollars
Expected annual sales revenue  Ten thousand yuan(RMB)
Expected investment payback period  Year
Expected employment figure People
Project description
Description of environment protection

Description of investor conditions
Description of project contents
Chikungunya Disease, a kind of mosquito infectious disease, might lead to chronic weakness, arthritis, and death in serious cases. Due to climate change, Chikungunya disease increases amongst those families affected by tropical mosquitos. Presently, the disease might take place in the northern areas, New York, and the south of Sydney. With increasing severity of morbidity, increase of outbreaks, and extensive geographical distribution of virus, Chikungunya vaccine is in short supply. Based on its dedicated SCV victor system, Sementis Ltd. is developing prophylactic vaccine for Chikungunya-stricken areas.
Company/Organisation Contacts
Advisory Interaction
                        Submit a message    (Warm Tip: Registered members can not submit messages until they log in.)
Message List
Home  |   News   |   Legal Service   | Data Service   |   Foreign IPAs |   National Development Zone   |  About Us | Customer Service   | Links | Announcement
Copyright:Ministry of Commerce of the People's Republic of China
Sponsor::Investment Promotion Agency of the Ministry of Commerce
Address:28 Donghou Lane, Andingmenwai, Dongcheng District, Beijing
Site Management:E-commerce and Information
Technology Division of the Ministry of Commerce
ICP Record No.:Beijing ICP 14022686
Postal Code:100710